Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN104109182A details high purity gemcitabine hydrochloride synthesis offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN105566367B details a palladium-free synthesis route for high-purity intermediates. This method offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN103554117B enables high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing with metal-free catalysis.
Novel iodine-catalyzed method for phenolic compounds. Metal-free, aqueous phase system ensures high purity and supply chain reliability for pharmaceutical intermediates.
Novel synthesis route for diazabicyclo derivatives offering enhanced structural diversity for pharmaceutical intermediate manufacturing and supply chain reliability globally.
Patent CN102439010A details a scalable copper-catalyzed cyclization for gamma secretase inhibitors, offering high purity and reduced impurities for pharmaceutical manufacturing.
Advanced post-processing technology reduces V320 and NDMA impurities in Valsartan manufacturing. Ensures supply chain safety and regulatory compliance for global pharmaceutical partners.
Advanced coupled synthesis technology for Vitamin B intermediates. Delivers high-purity Alpha-Acetyl-Gamma-Butyrolactone with optimized supply chain efficiency and cost reduction.
Patent CN112063670A reveals a stable adenylate cyclase method for cAMP production, offering reliable pharmaceutical intermediates supply with significant cost and environmental advantages.
Novel 2-step route for Selpercatinib via CN111057075B. High purity >99.5%, mild conditions, cost-effective manufacturing for RET inhibitors.
Advanced synthesis of 5-chloro-2,4-dihydroxypyridine offers high purity and scalable production for global pharmaceutical supply chains seeking cost-effective intermediates.
Patent CN109020872B details a novel method converting unwanted paroxetine isomers into valuable racemic intermediates, offering significant cost reduction and supply chain efficiency for pharmaceutical manufacturers.
Patent CN102675223B reveals a copper-catalyzed one-step synthesis for quinazolines. This method offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel 4-step synthesis of antiviral intermediate Phthiobuzone reduces bromine usage and improves scalability for reliable pharmaceutical supply chains.
Explore CN1108653A technology for synthesizing hyper-potent paclitaxel analogs. Offers superior solubility and antitumor activity for reliable API intermediate supply chains.
Novel synthetic route for Salvianolic Acid N offers high yield and mild conditions. Enhances supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN104592243B details a novel Sc(OTf)3 catalyzed route for Galantamine. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediates supply.
Novel manganese-catalyzed process for carfilzomib intermediates significantly reduces cost and waste. Reliable pharmaceutical intermediate supplier for global scale manufacturing.
Patent CN103396426B reveals novel NHC-Cu catalysis for chiral boronic acids. Enhances purity and reduces manufacturing costs for reliable pharmaceutical intermediate supply chains.
Patent CN103396426B reveals novel NHC-catalyzed synthesis. Enhances yield and stereoselectivity for diabetes and tumor drug intermediates.